Free tool
FAERS Monitor: Doxil (Liposomal)
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050718 or its brand name (Doxil (Liposomal), Doxorubicin Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
32,988
Serious
30,133
91% of reports
Hospitalization
12,409
Death reported
5,456
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use3,874
- febrile neutropenia3,562
- neutropenia2,221
- pyrexia1,828
- disease progression1,808
- product use in unapproved indication1,758
- nausea1,651
- anaemia1,539
- alopecia1,533
- vomiting1,328
- thrombocytopenia1,270
- diarrhoea1,156
- pneumonia1,103
- fatigue1,083
- hair colour changes1,080
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 365 |
| 2005 | 434 |
| 2006 | 431 |
| 2007 | 531 |
| 2008 | 576 |
| 2009 | 364 |
| 2010 | 392 |
| 2011 | 590 |
| 2012 | 769 |
| 2013 | 589 |
| 2014 | 466 |
| 2015 | 1,241 |
| 2016 | 1,079 |
| 2017 | 1,587 |
| 2018 | 1,975 |
| 2019 | 2,308 |
| 2020 | 3,545 |
| 2021 | 2,306 |
| 2022 | 3,066 |
| 2023 | 3,284 |
| 2024 | 2,933 |
| 2025 | 2,386 |
| 2026 | 1,771 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,171 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hair colour changesSignal | 1,080 | 60.5 | 56.9 | 57,690 |
| febrile neutropeniaSignal | 3,562 | 36.1 | 35.0 | 115,445 |
| neutropeniaSignal | 2,221 | 10.6 | 10.2 | 19,046 |
| disease progressionSignal | 1,808 | 9.9 | 9.4 | 14,278 |
| thrombocytopeniaSignal | 1,270 | 7.3 | 6.9 | 6,873 |
| anaemiaSignal | 1,539 | 5.2 | 4.9 | 5,190 |
| alopeciaSignal | 1,533 | 5.0 | 4.8 | 4,922 |
| product use in unapproved indicationSignal | 1,758 | 4.5 | 4.3 | 4,885 |
| pyrexiaSignal | 1,828 | 3.4 | 3.2 | 3,097 |
| off label useSignal | 3,874 | 2.8 | 2.7 | 4,757 |
| pneumoniaSignal | 1,103 | 2.2 | 2.1 | 709 |
| vomiting | 1,328 | 1.8 | 1.7 | 484 |
| nausea | 1,651 | 1.3 | 1.3 | 140 |
| diarrhoea | 1,156 | 1.1 | 1.1 | 21 |
| fatigue | 1,083 | 0.9 | 0.8 | 16 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.